分娩之外:美国子痫前期造成的人力与经济损失_第1页
分娩之外:美国子痫前期造成的人力与经济损失_第2页
分娩之外:美国子痫前期造成的人力与经济损失_第3页
分娩之外:美国子痫前期造成的人力与经济损失_第4页
分娩之外:美国子痫前期造成的人力与经济损失_第5页
已阅读5页,还剩43页未读, 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

November2026

McKinseyHealthInstitute

Beyonddelivery:The

humanandeconomictollofpreeclampsiaintheUS

Preeclampsiaaffectsaboutonein11birthsayearintheUnitedStates,

causingcomplicationsformothersandbabiesandcontributingto$28billionincosts.Moreinnovationandinvestmentcouldhelp.

Ataglance

—AnalysisofcommercialandMedicaidclaimsdataandpublishedliteraturesuggeststhatintheUnitedStatesalone,preeclampsiaaffectsanestimated325,000birthsannually,

contributestoseverematernalmorbidity,isassociatedwith1,000to2,200stillbirths,andislinkedtoover$28billionincostsoverthelifetimeofwomenwhodeveloppreeclampsia

everyyearandtheirchildren.

—Unlikemanyothercostlymedicalconditions,costsofpreeclampsiaarehighlyconcentratedandlikelyaddressable.Whilelifetimecostsaccountforasubstantialmajorityofthetotal

economicburden,approximatelyone-thirdofcostsareincurredarounddeliveryandthefirstyearpostpartumandarelargelydrivenbymaternalhospitalizationandneonatalintensive

care.

—Despitepreeclampsia’slargeburdenandunmetneed,thesolutionisoftendeliveringthe

baby,evenwhentheyarenotfullterm.Deliveryisthedefinitiveinterventionwhenmaternalorfetalrisksoutweighthebenefitsofcontinuingpregnancy.Improvementsinhealthaccessandcareusingexistingtools,aswellthedevelopmentofnew,effectivedisease-modifyingtherapies,couldimprovematernalandneonataloutcomesandreducehealthcarecosts.

Preeclampsiaisamultisystempregnancydisorderthattakesaheavytollonwomen’shealthintheUnitedStatesandaroundtheworld.1Itisassociatedwithnew-onsethypertensionafter

20weeks’gestation,thepresenceofexcessproteinintheurine,and/ormaternalorganor

placentaldysfunction.Itcanleadtoseverecomplications,includingdeath,formothersand

babies—especiallyformothersinlow-andmiddle-incomecountriesandBlackwomeninthe

UnitedStates.2Itseffectscanalsolastlongafterpregnancy:Womenwhohavehad

preeclampsiaandtheirchildrenfacehigherlong-termhealthrisks,particularlyofheartand

metabolicconditions.Severalstudieshaveestimatedthatwomenwithahistoryofpreeclampsiaexperienceatwotofourtimesincreasedriskofcardiovasculardisease.3

Preeclampsiahasgenerallybeenreportedtoaffectbetween5and8percentofpregnanciesintheUnitedStatesannually.AnewanalysisfromtheMcKinseyHealthInstituteconductedin

collaborationwiththeGatesFoundationhasfoundthatpreeclampsiaaffectsapproximatelyonein11livebirthsayear,or325,000of3.6millionannualbirths.4

1“Gestationalhypertensionandpreeclampsia:ACOGPracticeBulletin,number222,”Obstetrics&Gynecology,June2020.

Preeclampsiaresultsfromabnormalplacentaldevelopmentorotherriskfactorsthatrestrictbloodsupplytothefetus.Forthe

baby,thisreducesoxygenandnutrientsneededforhealthygrowth,increasingtheriskoffetalgrowthrestriction,pretermbirth

andothercomplications.Forthemother,thestresstotheplacentaresultsinreleaseofinflammatoryandanti-angiogenicproteinsintothebloodstream,whichcandamagebloodvessels,raisebloodpressure,andstrainmajororgans.Formore,seeK.KanasakiandR.Kalluri,“Thebiologyofpreeclampsia,”KidneyInternational,October2009.

2LeliaDuley,“Theglobalimpactofpre-eclampsiaandeclampsia,”SeminarsinPerinatology,June2009,Volume33,Number3;H.

O.Fasanyaetal.,“Acriticalreviewontheuseofraceinunderstandingracialdisparitiesinpreeclampsia,”JournalofAppliedLaboratoryMedicine,January2021,Volume6,Number1.

3LeanneBellamyetal.,“Pre-eclampsiaandriskofcardiovasculardiseaseandcancerinlaterlife:Systematicreviewandmeta-

analysis,”BMJ,November2007,Volume335,Number7627;LydiaJ.Leonetal.,“PreeclampsiaandcardiovasculardiseaseinalargeUKpregnancycohortoflinkedelectronichealthrecords:ACALIBERstudy,”Circulation,September24,2019,Volume140,Number13;GaiaBianchietal.,“Thedilemmaofchronickidneydiseaseandend-stagekidneydiseasefollowingpre-eclampsia:Aliteraturereviewandmeta-analysis,”InternationalUrologyandNephrology,December2025,Volume57,Number12;Pensee

Wuetal.,“Pre-eclampsiaisassociatedwithatwofoldincreaseindiabetes:Asystematicreviewandmeta-analysis,”Diabetologia,December2016,Volume59,Number12.

4The9percentfigureistakenfromGatesFoundationandMHIanalysisusingMerativeMarketScanCommercialclaimsdata

(2018–25)andCentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24)andappliedtothe3.6million

birthsintheUnitedStatesin2025.B.E.Hamilton,M.J.K.Osterman,andE.C.W.Gregory,Births:Provisionaldatafor2025,VitalStatisticsRapidReleaseReportNo.43,NationalCenterforHealthStatistics,April2026.

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS2

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS3

Everyyear,accordingtoouranalysisofcommercialandMedicaidclaims,preeclampsia’sdiseaseburdendrivesmorethan$28billioninlifetimeeconomicburdenforwomenwhodevelop

preeclampsiaintheUnitedStatesandfortheirchildren.5Whiletheseestimatesarefocusedontheimpactofpreeclampsiaonwomenandtheirchildren,thetrueburdenislikelygreater,as

preeclampsiaalsoaffectspartners,caregivers,andfamiliesmorebroadly.Approximately29

percent($8billion)ofcostsaremedicalcostsincurredbythehealthcaresystemwithinayearofdelivery.Theremainingcostsincludeanestimated$16billionto$18billionoflong-termmedicalcostsassociatedwithincreasedriskofchronicmaternalandchildhealthconditionsand

approximately$2billionto$3billioninsocietalcosts.Thehealthcareandeconomicburdenisparticularlyconcentratedamongwomenwithearly-onsetpreeclampsia(diagnosedearlierthan34weeksintopregnancy).Early-onsetdiseasemakesupapproximately20percentof

preeclampsiacases,butitaccountsforabout77percentofestimatedshort-termmedicalcostsamongaffectedbirthswithinoneyearofadmissionfordelivery.6

Despitethesehumanandeconomiccosts,thereiscurrentlynoapproveddisease-modifying

therapyforpreeclampsia.AsoutlinedintheWorldHealthOrganization’sGlobalroadmapfor

hypertensivedisordersofpregnancyfrom2026to2035,thedevelopmentofpreeclampsia

therapeuticshasnotbeensufficienttoaddresstheneed,withonlyahandfulofcandidatesin

activeclinicaldevelopment.7Barrierstodevelopmentoftherapeuticsincludeconcernsabout

liabilityformaternalandfetalsafetyduringtrials,relativelyuntestedregulatorypathwaysfor

novelmechanisms,andlackofcoordinationacrossresearchers,innovators,andpolicy-makers.8Thedevelopmentofnewtherapeuticsthatpreventorslowdiseaseprogression,alongside

improvementsinriskidentification,antenatalmanagement,andpostpartumfollow-up,could

improvematernalandneonataloutcomesandreducetheburdenassociatedwiththecondition.

ThisanalysiscomplementsMHI’srecentCAREforWomenreport,whichhighlightedgapsin

caredeliveryforpregnancyandcardiovasculardisease,includinghypertensivedisorders.ItalsobuildsonMHI’s2025reportBlueprinttoclosethewomen’shealthgap,whichfoundthat

closingthegapontreatmentformaternalhypertensivedisordersrepresentspotentialestimatedgainsof0.85millionannualdisability-adjustedlifeyears(DALYs).

Thispaperfocusesonopportunitiesforinnovatorsandinvestorstogeneratenewapproachestopreeclampsiapreventionandtreatment,basedonthehumanandeconomicburdenof

preeclampsia.Whileitoutlinessomeopportunitiestoimprovecaredeliverywithexistinginterventions,thisisnotaprimaryfocusofthepaper.

pidReport.Ap

5GatesFoundationandMHIanalysisusingMerativeMarketScanCommercialclaimsdata(2018-2025);CentersforMedicare&

MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchdatabases.Anyanalysis,interpretation,orconclusionbasedonthesedataissolelythatofthe

authorsandnotMerative.

6GatesFoundationandMHIanalysisfoundthatamongUSbirths,9percentofmotherswillbediagnosedwithpreeclampsia,whichisinclusiveofthe2percentofmotherswhohaveearly-onsetpreeclampsia.

7Globalroadmapforhypertensivedisordersofpregnancyfrom2026to2035andbeyond,WorldHealthOrganization,October

2026;“Preeclampsiaandfetalgrowthrestriction,”DiaMedicaTherapeutics,accessedOctober2026;GunvorEkman-Ordebergetal.,“Tafoxiparin,anoveldrugcandidateforcervicalripeningandlaboraugmentation:Resultsfrom2randomized,placebo-

controlledstudies,”AmericanJournalofObstetricsandGynecology,March2024,Volume230,Number3S;“AmoytopBiotech’spegfilgrastimgainsNMPAapprovalforpreeclampsiaclinicaltrials,”FinelineCube,January7,2025;“AphaseI,randomized,

cross-over,single-center,single-dosefastedstudyofEG-101IVinjection(EG-ZNMP-01)inhealthyvolunteerstoserveasa

safetylead-infordosinginpregnantwomenwithseverepre-eclampsia,”NCT07327255,ClinicalT,accessedOctober

2026;“Anopen-label,dosefindingstudytoevaluatethesafety,tolerability,pharmacokinetics,andpharmacodynamicsofsingleascendingsubcutaneousdosesofCBP-4888inhospitalizedparticipantswithpretermpreeclampsiareceivingstandardofcare,expectantmanagement,”NCT07282171,ClinicalT,accessedOctober2026.

8Globalroadmapforhypertensivedisordersofpregnancyfrom2026to2035andbeyond,WorldHealthOrganization,October2026.

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS4

Prevalenceandeffectsofpreeclampsia

MHIanalysisofUScommercialandMedicaidclaimsfoundthatapproximately9percentof

pregnancyepisodesprecedinglivebirthsmetthestudydefinitionofpreeclampsia,

correspondingtoroughly325,000birthsannuallywhenappliedtotheUSbirthpopulation.9(Formore,seesidebar,“Methodology.”)Preeclampsiaisassociatedwithmaternalmortalityand

seriousmaternalcomplications,includingacutekidneyinjury,HELLPsyndrome,stroke,andplacentalabruption,anditincreasestherisksoffetalgrowthrestriction,medicallyindicatedpretermdelivery,andstillbirth.10

ThisreportfocusesonpreeclampsiaintheUnitedStatesspecifically,becauseoftheavailabilityofclaimsdata,butpreeclampsiaisaworldwideissue.11Preeclampsiaandresultingeclampsiaarealeadingcauseofmaternalmorbidityandmaternalmortalityglobally(hypertensivedisorders

causeanestimated42,000maternaldeaths12and500,000infantdeathsannually13)andisoneofthetopsixcausesofmaternalmortalityintheUnitedStates.14IntheUnitedStatesalone,

preeclampsialeadsto1,000to2,200stillbirthseveryyear.15

Inanycountry,establishedriskfactorsforpreeclampsiaincludetype1ortype2diabetes,

previoushypertension,obesity,familyhistoryofpreeclampsia(includingpartner’sgeneticsandfamilyhistory),16priorpreeclampsia,firstpregnancy,andextremesofmaternalage.17Inthe

UnitedStates,theprevalenceofsomeoftheseriskfactorshasincreasedsubstantially:From2010to2021,ratesofchronichypertensionincreasedfrom1.2percentto2.7percent,ratesofpregestationaldiabetesincreasedfrom0.7percentto1.1percent,ratesofwomenhavingtheirfirstchildatage35orolderincreasedfrom14.7percentto20.1percent,andratesofobesityincreasedfrom22.5percentto30.5percent.18

Forthisanalysis,preeclampsiaisgroupedintothreetiming-basedcategories:early-onset,late-onset,andpostpartumpreeclampsia(Exhibit1).

—Early-onsetpreeclampsia,occurringbefore34weeksofgestation,19isoftenlinkedto

9PrevalenceofpreeclampsiainMedicaidandcommercialdatasetsis9percent.MerativeMarketScanCommercialclaimsdata(2018–25);CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchDatabases.Anyanalysis,interpretation,or

conclusionbasedonthesedataissolelythatoftheauthorsandnotMerative.

10HELLP(hemolysis,elevatedliverenzymes,lowplateletcount)isarareformofpreeclampsia.Formore,see“HELLPsyndrome,”ClevelandClinic,lastupdatedMarch27,2024;SaroshRanaetal.,“Preeclampsia:Pathophysiology,challenges,and

perspectives,”CirculationResearch,March29,2019,Volume124;MisganawFikrieMelesseetal.,“MaternaloutcomesofseverepreeclampsiaandeclampsiaandassociatedfactorsamongwomenadmittedatreferralhospitalsofAmhararegionalstate,

institutional-basedcross-sectionalstudy,North-WestEthiopia,”FrontiersinGlobalWomen’sHealth,March27,2025,Volume

6;ThaísAlquezarFaccaetal.,“Whyispreeclampsiastillanimportantcauseofmaternalmortalityworldwide?,”RevistaBrasileiradeGinecologiaeObstetrícia,October2020,Volume42,Number9.

11JussaraMayrinkandZilmaSilveiraNogueiraRei,“Pre-eclampsiainlow-andmiddle-incomesettings:Whatarethebarrierstoimprovingperinataloutcomesandevidence-basedrecommendations?,”InternationalJournalofGynecology&Obstetrics,

January2024.

12“Pre-eclampsia,”WorldHealthOrganizationfactsheet,October6,2026.

13GenomicsandPrecisionHealthBlog,“Preeclampsia,genomicsandpublichealth,”blogentrybyEricaL.DawsonandMuinJ.Khoury,CentersforDiseaseControlandPrevention(CDC),October25,2022.

14TiffanyShihetal.,“TherisingburdenofpreeclampsiaintheUnitedStatesimpactsbothmaternalandchildhealth,”AmericanJournalofPerinatology,March2016,Volume33,Number4.

15“Answerstoourmostfrequentlyaskedquestions,”PreeclampsiaFoundation,updatedMarch4,2025;“DatafromthePregnancyMortalitySurveillanceSystem,”CentersforDiseaseControlandPrevention(CDC),December18,2025(figureisrelatedtoHDPsandpotentiallyoverstated).

16RolvSkjaervenetal.,“Recurrenceofpre-eclampsiaacrossgenerations:Exploringfetalandmaternalgeneticcomponentsinapopulationbasedcohort,”BMJ,October15,2005,Volume331,Number7521.

17“Preeclampsiaandpregnancy,”AmericanCollegeofObstetriciansandGynecologists(ACOG)women’shealthinfographic,accessedSeptember2026.

18MariamK.Ayyash,RodneyMcLarenJr.,andMajidShaman,“TrendsinpreeclampsiariskfactorsintheUSfrom2010to2021,”JAMA,June10,2024,Volume332,Number2.

19MariaKariori,VasilikiKatsi,andCostasTsioufis,“Latevs.earlypreeclampsia,”InternationalJournalofMolecularSciences,November15,2025,Volume6,Number22.

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS5

problemswithhowtheplacentadevelops.Inahealthypregnancy,thebloodvessels

supplyingtheplacentawidentoprovideenoughblood,nutrients,andoxygentosupportthegrowingbaby.Inearly-onsetpreeclampsia,thisprocessmaynothappennormally.Emergingscientificresearchpointstoseveralbiologicalmechanisms,includingabnormaltrophoblastinvasionandreduceddevelopmentofuterinespiralarteries.20Early-onsetpreeclampsiacanhaveseriousconsequencesforbothmotherandbaby.Forthemother,itcanleadto

problemswithmajororgans,aseriouscomplicationknownasHELLPsyndrome,orearlyseparationoftheplacentafromthewomb.Forthebaby,reducedbloodflowthroughtheplacentacanrestrictgrowthandrequireearlydeliveryforthebaby.21Babiesbornvery

prematurelyaremorelikelytorequirecareinaneonatalintensivecareunit.

—Late-onsetpreeclampsiadevelopslaterinpregnancyandismorecommoninwomenwith

certainriskfactors,includinglong-termhighbloodpressure,ahigherbodyweight,older

maternalage,andfirstpregnancies.22Comparedwithearly-onsetpreeclampsia,itismore

oftenlinkedtothemother’sunderlyingheart,bloodvessel,andmetabolichealth,although

bothearly-andlate-onsetpreeclampsiasharemanyofthesamebiologicalfeatures.23Late-onsetpreeclampsiacanincreasetheriskofcomplicationsaroundthetimeofdeliveryandisalsolinkedtoanincreasedriskofheartandkidneyproblemslaterinlife.24Becauseit

developslaterinpregnancy,deliverycanoftentakeplaceatornearfullterm,whichreducessomeoftheriskstothebabyassociatedwithbeingbornprematurely.

—Postpartumpreeclampsiapresentsafterdeliveryandisgenerallydefinedasnew-onset

preeclampsiafrom48hoursthroughsixweekspostpartum.Mostdelayedpresentations

occurwithinthefirstseventotendaysofdelivery.25Giventhatsymptomsoftendevelop

afterhospitaldischarge,postpartumpreeclampsiaisoftenundiagnoseduntiltheconditionbecomessevere,increasingtheriskofstroke,seizures,andbraininjury.Postpartum

preeclampsiamayoccurdenovoafterapregnancywithouthypertensionorfollowingantepartumhypertensivedisease.Itspathophysiologyisnotfullyunderstood.26

Theeffectsofpreeclampsiaalsoreachfarbeyondpregnancy,shapingawoman’shearthealthfortherestofherlife.Studiesoncardiovascularriskfindthatpreeclampsiaisassociatedwithafourfoldincreaseinriskofheartfailureandadoublingoftheriskofcoronaryheartdisease,

stroke,andmortalityduetocardiovasculardisease.Preeclampsiaisalsoassociatedwithan

increasedriskofchronichypertension,venousthromboembolism,andotherconditions.27This

researchpointstotheimportanceofpreeclampsiaasnotonlyanacutepregnancycomplicationbutalsoanimportantmarkeroflifelonghealthrisk.

20BertholdHuppertz,“Thecriticalroleofabnormaltrophoblastdevelopmentintheetiologyofpreeclampsia,”CurrentPharmaceuticalBiotechnology,September2018,Volume19,Number10.

21GaetanoSantulli,UrnaKansakar,andFahimehVarzideh,“Epidemiologyandpathophysiologyofpreeclampsia:Newmechanisticinsights,”Hypertension,May2025,Volume82,Number5.

22“Answerstoourmostfrequentlyaskedquestions,”PreeclampsiaFoundation,updatedMarch4,2025.

23AnnaBaylisetal.,“Predictionandpreventionoflate-onsetpre-eclampsia:Asystematicreview,”FrontiersinMedicine,November2024,Volume11.

24ErnawatiErnawatietal.,“Theriskofpersistenthypertensionandchronickidneydiseaseinearly-andlate-onsetpreeclampsia:Areportfromdevelopingcountry,”Cureus,December13,2023,Volume15,Number12.

25“Postpartumpreeclampsia:Symptomsandcauses,”MayoClinic,August17,2021;AlisseHauspurgandArunJeyabalan,

“Postpartumpreeclampsiaoreclampsia:Definingitsplaceandmanagementamongthehypertensivedisordersofpregnancy,”AmericanJournalofObstetrics&Gynecology,February2022,Volume226,Number2S.

26“Postpartumpreeclampsia,”PreeclampsiaFoundation,updatedMarch12,2026.

27PenséeWuetal.,“Preeclampsiaandfuturecardiovascularhealth:Asystematicreviewandmeta-analysis,”Circulation

CardiovascularQualityOutcomes,February2017,Volume10,Number2;LeanneBellamyetal.,“Pre-eclampsiaandriskof

cardiovasculardiseaseandcancerinlaterlife:Systematicreviewandmeta-analysis,”BMJ,November2007,Volume335,

Number7627;LydiaJ.Leonetal.,“PreeclampsiaandcardiovasculardiseaseinalargeUKpregnancycohortoflinkedelectronichealthrecords:ACALIBERstudy,”Circulation,September24,2019,Volume140,Number13;GaiaBianchietal.,“Thedilemmaofchronickidneydiseaseandend-stagekidneydiseasefollowingpre-eclampsia:Aliteraturereviewandmeta-analysis,”

nternationalUrologyandNephrology,December2025,Volume57,Number12.

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS6

PreeclampsiaoutcomesvarysubstantiallyacrossracialgroupsintheUnitedStates.

Preeclampsiatreatmentexperienceandintensityofcareutilizationdifferbyrace,

socioeconomic,andgeographicalfactors.Notably,Blackwomenareapproximately1.6times

morelikelythanwhitewomentodeveloppreeclampsia,andtheyexperiencehigherratesof

severecomplicationsandpregnancy-relateddeaths.28Thedisparitymaybeevenlargerfor

early-onsetdisease:InoneCaliforniacohort,theprevalenceofpreeclampsiawithdelivery

before32weekswasapproximatelythreetimesashighamongBlackwomenasamongWhitewomen(0.41percentversus0.13percent).29Existingresearchindicatesimportantcontributionsfromsocialdeterminantsofhealth,structuralinequities,differentialexposuretoracismand

chronicstress,andvariationinaccesstoandqualityofcare.30

Theexperienceandintensityofcareamongwomenwithpreeclampsiaalsodiffersaccordingtotypeofinsurance.Around41percentofpregnanciesarecoveredbyMedicaid,andaround52

percentarecoveredbyprivateinsurance(withtheremaining7percentusingself-payorothertypesofcoverage).31OneUSstudyfurtherfoundthatforwomenwithhypertensivedisordersofpregnancyspecifically,54percentarecoveredbyMedicaid,44percentarecoveredbyprivateinsurance,and2percentbyothertypesofcoverage.32Inouranalysisofdeliveriescoveredby

Medicaidversuscommercialinsurance,theaveragegestationalageforwomenwithearly-onsetpreeclampsiawassimilartowomenwithcommercialinsurance(estimated33-34weeks),but

Medicaidmemberswithpreeclampsiahadapproximately3.3to3.5timestheemergency

departmentutilizationandfourtoseventimestheintensivecareunit(ICU)utilizationof

commerciallyinsuredpatients.WithintheMedicaidpopulationanalyzed,Blackwomenwith

preeclampsiahadhigherobservedratesofcesareandelivery,emergencydepartmentutilization,andneonatalintensivecareunit(NICU)admissionthanotherMedicaidmemberswith

preeclampsia.33Thesedifferencesareobservationalandmayreflectvariationinbaselinehealth,socialdeterminantsofhealth,accesstocare,caredelivery,andotherfactors.34

Geographicdisparitiesarealsoevidentintermsofexperienceandutilizationofcare.Inour

analysis,amongMedicaidmemberswithpreeclampsia,womenlivinginruralareashadhigherICUutilizationthantheirurbancounterparts,includingapproximately16percenthigherratesamongwomenwithearly-onsetpreeclampsiaand14percenthigherratesamongwomenwithpostpartumpreeclampsia.35Thesedifferencesmayreflectvariationindiseaseseverity,referralpatterns,accesstocare,caredelivery,andothercontextualfactors;theclaimsdatadonot

establishthemechanismsunderlyingtheobservedgeographicdifferences.

Forallitsprevalenceandseriousness,preeclampsiastillhasnoapprovedtreatmentthat

reversesormeaningfullychangesthediseaseonceithasdeveloped.Managementofindividualsatincreasedriskofpreeclampsiaincludeslow-doseaspirin,thoughuptakeremainslimited.

gyNephrology

28HenriettaO.Fasanyaetal.,“Acriticalreviewontheuseofraceinunderstandingracialdisparitiesinpreeclampsia,”JournalofAppliedLaboratoryMedicine,January12,2021,Volume6,Number1.

29JuanYangetal.“Racial-ethnicdifferencesinmidtrimestermaternalserumlevelsofangiogenicandantiangiogenicfactors,”AmericanJournalofObstetrics&Gynecology,September2016,Volume215,Number3.

30FrancesConti-Ramsden,AntoniodeMarvao,andLucyC.Chappell,“Pregnancydisordersandmaternalconsequences:Ethnicdisparitiesinhypertensivedisordersofpregnancy,”Reproduction,May2025,Volume169,Number6.

31ClaudiaP.ValenzuelaandMichelleJ.K.Osterman,“Characteristicsofmothersbysourceofpaymentforthedelivery:UnitedStates,2021,”NCHSDataBrief,Number468,NationalCenterforHealthStatistics,2023.

32KarenS.Greineretal.,“Associationbetweeninsurancetypeandpregnancyoutcomesinwomendiagnosedwithhypertensivedisordersofpregnancy,”JournalofMaternal-Fetal&NeonatalMedicine,April2020,Volume33,Number8.

33CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021-2024),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).

34MerativeMarketScanCommercialclaimsdata(2018–25);CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeen

suppressed).CertaindatausedinthisstudyweresuppliedbyMerativeaspartofoneormoreMerativeMarketScanResearchDatabases.Anyanalysis,interpretation,orconclusionbasedonthesedataissolelythatoftheauthorsandnotMerative.

35CentersforMedicare&MedicaidServices,100percentMedicaiddata(2021–24),obtainedviatheCMSInnovatorResearchIdentifiableFiles(valueswithlessthan11observationshavebeensuppressed).

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS7

Exhibit1

Beyonddelivery:ThehumanandeconomictollofpreeclampsiaintheUS8

Managementalongthediseasecourseincludesbutisnotlimitedtoclosematernalandfetal

surveillance,treatmentofseverehypertensionwithantihypertensivemedications,magnesiumsulfateforseizureprophylaxiswhenindicated,andappropriatelytimeddelivery.36TherapeuticcandidatesinpreclinicalandclinicaldevelopmentincludetherapiesthattargetsFLT-1s37(a

proteinproducedlargelybytheplacenta)andthosethatdilatebloodvesselsandreducebloodpressure,38butsubstantialunmetneedremainsfordisease-modifyingtreatmentsandfor

continuedresearchintotheincompletelyunderstoodmechanismsunderlyingpreeclampsia.

Thehumanandeconomiccostsofpreeclampsia

Beyonditssubstantialmortalityandmorbidityburden,preeclampsiaisassociatedwithbillionsofdollarsofhealthcareandsocietalcosts(Exhibit2).Theanalysisinth

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论